Related Experiment Videos
Effect of intrathecal baclofen on bladder and sphincter function.
J B Nanninga1, F Frost, R Penn
1Department of Urology, Northwestern University Medical School, Chicago, Illinois.
The Journal of Urology
|July 1, 1989
Summary
A programmable baclofen pump improved severe spasticity and enhanced bladder and sphincter function in patients. This device offers value for managing lower urinary tract issues in spasticity-related conditions.
Area of Science:
- Neurology
- Urology
- Biomedical Engineering
Background:
- Severe spasticity significantly impacts patient quality of life.
- Spasticity often leads to complications in bladder and sphincter function.
- Existing treatments for spasticity-related lower urinary tract dysfunction can be limited.
Purpose of the Study:
- To evaluate the efficacy of a programmable baclofen pump in managing severe spasticity.
- To assess the impact of baclofen pump therapy on lower urinary tract function, specifically bladder and sphincter control.
- To determine the potential of this system in improving urological outcomes for patients with spasticity.
Main Methods:
- Implantation of a programmable baclofen pump in seven patients with severe spasticity.
- Monitoring of patient symptoms and functional outcomes pre- and post-implantation.
- Assessment of changes in bladder and sphincter function.
Main Results:
- All seven patients reported relief from severe spasticity following pump implantation.
- Significant improvements were observed in bladder function among the treated patients.
- Enhanced sphincter control was noted, contributing to better urinary continence.
Conclusions:
- Programmable baclofen pump therapy is effective in alleviating severe spasticity.
- The system demonstrates considerable value in improving lower urinary tract function, including bladder and sphincter control.
- This therapeutic approach offers a promising solution for patients suffering from spasticity-induced urological dysfunction.